October, 2018

The following amendments have been made to the ‘Glycotest Completes $10m Series A Round with Fosun’ announcement (RNS Number: 6823E) released on 22 October 2018 at 07:00AM:   The following sentence:   Upon satisfaction of the contingent ODI approval, NetScientific’s controlling interest will be 50.4% of Glycotest Inc. calculated on a fully-diluted basis following the closing of the Series A Financing.   Has been …